In HER-2-positive and TNBC subtypes, we observed a positive trend suggesting that higher percentages of N20-CD8 + T cells may correlate with better outcomes; however, these findings did not reach statistical significance, possibly due to limited sample sizes (Supplementary Fig. 13 ).
← all excerpts
Spatial proximity of CD8<sup>+</sup> T cells to tumor cells predicts neoadjuvant therapy efficacy in breast cancer.
1
—
—